Cargando…

Remarkable Shrinkage of a Growth Hormone (GH)-secreting Macroadenoma Induced by Somatostatin Analogue Administration: A Case Report and Literature Review

Acromegaly is caused by excessive growth hormone secretion, usually from pituitary adenomas. Somoatostatin analogues are widely used as primary or adjunctive therapy in the management of acromegaly. In this report, we present a case with remarkable shrinkage of a tumor after relatively short-term oc...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kurahashi, Kiyoe, Endo, Itsuro, Kondo, Takeshi, Morimoto, Kana, Yoshida, Sumiko, Kuroda, Akio, Aihara, Ken-ichi, Matsuhisa, Munehide, Nakajima, Kohei, Mizobuchi, Yoshifumi, Nagahiro, Shinji, Abe, Masahiro, Fukumoto, Seiji
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The Japanese Society of Internal Medicine 2017
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5643174/ https://www.ncbi.nlm.nih.gov/pubmed/28824054 http://dx.doi.org/10.2169/internalmedicine.8223-16

Ejemplares similares

Suppression of the Hypothalamic-pituitary-adrenal Axis by Maximum Androgen Blockade in a Patient with Prostate Cancer
por: Kondo, Takeshi, et al.
Publicado: (2016)

Basal insulin requirement in patients with type 1 diabetes depends on the age and body mass index
por: Mitsui, Yukari, et al.
Publicado: (2021)

Association of accumulated advanced glycation end‐products with a high prevalence of sarcopenia and dynapenia in patients with type 2 diabetes
por: Mori, Hiroyasu, et al.
Publicado: (2019)

Vascular Endothelial Function Is Associated with eGFR Slope in Female and Non-Smoking Male Individuals with Cardiovascular Risk Factors: A Pilot Study on the Predictive Value of FMD for Renal Prognosis
por: Masuda, Shiho, et al.
Publicado: (2023)

Cross-Sectional and Longitudinal Associations between Skin Autofluorescence and Tubular Injury Defined by Urinary Excretion of Liver-Type Fatty Acid-Binding Protein in People with Type 2 Diabetes
por: Yamagami, Hiroki, et al.
Publicado: (2023)

Plasma heparin cofactor II activity is inversely associated with albuminuria and its annual deterioration in patients with diabetes
por: Hara, Tomoyo, et al.
Publicado: (2021)

Presurgical somatostatin receptor ligand treatment does not affect tumor consistency in GH-secreting pituitary macroadenomas
por: Araujo-Castro, Marta, et al.
Publicado: (2020)

Plasma Heparin Cofactor II Activity Is Inversely Associated with Hepatic Fibrosis of Non-Alcoholic Fatty Liver Disease in Patients with Type 2 Diabetes Mellitus
por: Hara, Tomoyo, et al.
Publicado: (2023)

Dehydroepiandrosterone Sulfate, an Adrenal Androgen, Is Inversely Associated with Prevalence of Dynapenia in Male Individuals with Type 2 Diabetes
por: Yasui, Saya, et al.
Publicado: (2023)

New risk factors of severe hypoglycemia
por: Matsuhisa, Munehide, et al.
Publicado: (2018)

Dense calcification in a GH-secreting pituitary macroadenoma
por: Ibrahim, Ramez, et al.
Publicado: (2014)

Novel method utilizing bisulfite conversion with dual amplification‐refractory mutation system polymerase chain reaction to detect circulating pancreatic β‐cell cfDNA
por: Okada, Asami, et al.
Publicado: (2022)

Skeletal FGFR1 signaling is necessary for regulation of serum phosphate level by FGF23 and normal life span
por: Takashi, Yuichi, et al.
Publicado: (2021)

The Role of Heparin Cofactor II in the Regulation of Insulin Sensitivity and Maintenance of Glucose Homeostasis in Humans and Mice
por: Kurahashi, Kiyoe, et al.
Publicado: (2017)

A Review of Insulin-Dosing Formulas for Continuous Subcutaneous Insulin Infusion (CSII) for Adults with Type 1 Diabetes
por: King, Allen B., et al.
Publicado: (2016)

A Rare Case of Thyrotropin Secreting Pituitary Macroadenoma Primarily Treated With Somatostatin Analogue
por: Elsheikh, Arwa Mahmoud, et al.
Publicado: (2021)

Current Topics in Sports-related Head Injuries: A Review
por: NAGAHIRO, Shinji, et al.
Publicado: (2014)

A Review of Sport-Related Head Injuries
por: Mizobuchi, Yoshifumi, et al.
Publicado: (2016)

Growth Hormone (GH) and Thyroid Stimulating Hormone (TSH) Co-Secreting Pituitary Macroadenoma
por: Maliakal, Alvin, et al.
Publicado: (2021)

SUN-463 Tumor Shrinkage with Preoperative Relacorilant Therapy in Two Patients with Cushing Disease Due to Pituitary Macroadenomas
por: Terzolo, Massimo, et al.
Publicado: (2019)

Thyrotoxicosis with absence of clinical features of acromegaly in a TSH- and GH-secreting, invasive pituitary macroadenoma
por: Johnston, Philip C, et al.
Publicado: (2015)

GH-secreting pituitary macroadenoma (acromegaly) associated with progressive dental malocclusion and refractory CPAP treatment
por: Miranda-Rius, Jaume, et al.
Publicado: (2017)

Somatostatin, as a Bridge Between the GH-Axis and the Gth-Axis
por: Mizrahi, Naama, et al.
Publicado: (2021)

High prevalence and clinical impact of dynapenia and sarcopenia in Japanese patients with type 1 and type 2 diabetes: Findings from the Impact of Diabetes Mellitus on Dynapenia study
por: Mori, Hiroyasu, et al.
Publicado: (2020)

Safety of the batteries and power units used in insulin pumps: A pilot cross‐sectional study by the Association for the Study of Innovative Diabetes Treatment in Japan
por: Murata, Takashi, et al.
Publicado: (2017)

Advanced glycation end‐products are a risk for muscle weakness in Japanese patients with type 1 diabetes
por: Mori, Hiroyasu, et al.
Publicado: (2016)

Craniotomy for cerebellar hemangioblastoma excision in a patient with von Hippel–Lindau disease complicated by uncontrolled hypertension due to pheochromocytoma
por: Mizobuchi, Yoshifumi, et al.
Publicado: (2015)

Transcriptome of GH-producing pituitary neuroendocrine tumours and models are significantly affected by somatostatin analogues
por: Saksis, Rihards, et al.
Publicado: (2023)

Skin Autofluorescence is Associated with Early-stage Atherosclerosis in Patients with Type 1 Diabetes
por: Osawa, Saeko, et al.
Publicado: (2017)

Comparison of continuous subcutaneous insulin infusion treatment and multiple daily injection treatment on the progression of diabetic complications in Japanese patients with juvenile‐onset type 1 diabetes mellitus
por: Masuda, Takafumi, et al.
Publicado: (2022)

Role of Receptor Profiling for Personalized Therapy in a Patient with a Growth Hormone-Secreting Macroadenoma Resistant to First-Generation Somatostatin Analogues
por: Alexandraki, Krystallenia I., et al.
Publicado: (2019)

A vicious cycle between acid sensing and survival signaling in myeloma cells: acid-induced epigenetic alteration
por: Amachi, Ryota, et al.
Publicado: (2016)

Pasireotide-Induced Shrinkage in GH and ACTH Secreting Pituitary Adenoma: A Systematic Review and Meta-Analysis
por: Mondin, Alessandro, et al.
Publicado: (2022)

Neurocytoma mimicking macroadenoma
por: Nery, Breno, et al.
Publicado: (2019)

Mean GH profile is more accurate than single fasting GH in the evaluation of acromegaly disease control during somatostatin receptor ligands therapy
por: Bona, C., et al.
Publicado: (2022)

Use of iGlarLixi for Management of Type 2 Diabetes in Japanese Clinical Practice: SPARTA Japan, a Retrospective Observational Study
por: Matsuhisa, Munehide, et al.
Publicado: (2022)

Use of iGlarLixi for the Management of Type 2 Diabetes in Japanese Clinical Practice: Prior Treatment Subgroup Analysis of the SPARTA Japan Study
por: Miyoshi, Hideaki, et al.
Publicado: (2023)

Effects of combination therapy: somatostatin analogues and dopamine agonists on GH and IGF1 levels in acromegaly
por: VALEA, ANA, et al.
Publicado: (2015)

Long-term effects of somatostatin analogues in rat GH-secreting pituitary tumor cell lines
por: Dicitore, A., et al.
Publicado: (2021)

A Case of Hypocalcemia with Severe Vitamin D Deficiency following Treatment for Graves' Disease with Methimazole
por: Miyashita, Kazuyuki, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_595f2naq6jukp6fu1kjoidq4pb